Clinical Trials Sponsored by Birken AG

Total 4099 results

Biogen

Completed

PeptoBismol® Use to Reduce Gastrointestinal Events in Healthy Volunteers Receiving DMF [Tecfidera®] Twice Daily

Healthy

United States
Biogen

Completed

Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta (RENeu)

Relapsing-Remitting Multiple Sclerosis

New Zealand, Australia
Biogen

Completed

Avonex Safety and Tolerability in Chinese Subjects With Relapsing Multiple Sclerosis (MS) (Avonex China)

Multiple Sclerosis

China
Biogen

Completed

Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS

Relapsing-remitting Multiple Sclerosis

Belgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
Biogen

Completed

MATRIX: Measuring Neutralizing Antibodies in the Patients Treated With Interferon Beta 1a IM, in Mexico and Colombia (MATRIX)

Multiple Sclerosis

Colombia, Mexico
Biogen

Completed

Effect of Food and Antacid on BIIB021 With Advanced Solid Tumors

Advanced Solid Tumors

United States
Biogen

Completed

Study in Healthy Volunteers to Establish the Bioequivalence of Two Different Manufacturers.

Healthy Volunteers

United States
Biogen

Terminated

Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma

Colorectal Cancer | Metastases

United States
Biogen

Completed

Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis (PROOF)

Multiple Sclerosis

United States, Australia, Austria, Canada
Biogen

Completed

Dose-Finding Safety Study of BIIB014 in Combination With Levodopa in Moderate to Late Stage Parkinson's Disease

Parkinson's Disease

United Kingdom, Israel, India
Biogen

Completed

GER-009-06-AVX Early Therapy in Multiple Sclerosis (FIT)

Relapsing-Remitting Multiple Sclerosis
Biogen

Completed

Patient Satisfaction Study of Single-Use Autoinjector for the Delivery of Pre-Filled Avonex Syringe

Multiple Sclerosis
Biogen

Completed

A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy Volunteers

Multiple Sclerosis
Biogen

Completed

Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? (FLAIR)

Relapsing Remitting Multiple Sclerosis

Belgium, Luxembourg, United Kingdom
Biogen

Terminated

Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

United States
Biogen

Completed

Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102)

Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma

United States, Canada
InnoMedica Schweiz AG

Not yet recruiting

Estimates of the Short-term Efficacy of Talineuren (TLN) and Placebo in Patients With Parkinson Disease

Parkinson Disease

Switzerland
TOLREMO therapeutics AG

Recruiting

A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors (TT-CSP-001)

Cancer | Adult Solid Tumor | Advanced Solid Tumor | Adult Disease

Spain, Switzerland
CDR-Life AG

Recruiting

First in Human Study of CDR404 in HLA-A*02:01 Participants With MAGE-A4 Expressing Solid Tumors

Select Advanced Solid Tumors

United States, Denmark
Noema Pharma AG

Recruiting

A Study of NOE-115 in Women With Vasomotor Symptoms Due to Menopause

Hot Flashes | Menopause | Menopause Syndrome

United States
Ivoclar Vivadent AG

Recruiting

Clinical Evaluation of a New Flowable and a New Sculptable Universal Bulk-fill Composite for Direct Restorative Treatment

Insufficient Dental Filling or Primary Caries (Class I or II Cavities in Premolars or Molars)

Liechtenstein
Marinomed Biotech AG

Recruiting

Lubricating Effectiveness of Carragelose Eye Drops in Patients Affected by Mild to Moderate Dry Eye

Dry Eye Syndromes

Spain
Versameb AG
PPD

Not yet recruiting

A Phase 2a Study To Evaluate VMB-100 In Females With Stress Urinary Incontinence

Stress Urinary Incontinence
Spital Thurgau AG

Recruiting

Patch Study (Patch-augmented Rotator Cuff Repair)

Rotator Cuff Tears

Switzerland
Alentis Therapeutics AG

Recruiting

Rescue of Nephrons With ALE.F02 (RENAL-F02) (RENAL-F02)

Glomerulonephritis Rapidly Progressive

Czechia, Spain, Germany, Denmark, Italy, United Kingdom, France, Switzerland, Sweden, Turkey
Stereotaxis
Osypka AG

Recruiting

The MAGiC™ Cardiac Ablation European Study (MAGiC-FEST)

Arrhythmias, Cardiac

Denmark, Lithuania
Alentis Therapeutics AG

Recruiting

A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild Cirrhosis (FEGATO-01)

Liver Cirrhosis | Advanced Liver Fibrosis

United States, Germany, Romania, Slovakia
Molecular Partners AG

Recruiting

Study of MP0533 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Leukemia | Acute | Relapsed | Myeloid

Netherlands, France, Lithuania, Switzerland
Rehaklinik Zihlschlacht AG

Recruiting

Myosuit-based Gait Training

Neurologic Gait Disorder

Switzerland
Cinclus Pharma AG

Recruiting

A Study to Investigate the Pharmacokinetics and ECG Effects of Linaprazan Glurate

GERD | Pharmacokinetics | Cardiodynamic ECG | Safety, and Tolerability

Sweden
Bühlmann Laboratories AG

Recruiting

BÜHLMANN fPELA in the Diagnosis of Exocrine Pancreatic Insufficiency

Exocrine Pancreatic Insufficiency

Germany
S.L.A. Pharma AG

Recruiting

EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2)

SARS-CoV-2

Spain, United Kingdom
S.L.A. Pharma AG

Not yet recruiting

Metronidazole Ointment in Non-healing Pilonidal Sinus Wounds

Pilonidal Sinus

Turkey
TRB Chemedica AG

Recruiting

Efficacy and Safety of Ostenil® Plus in the Treatment of Coxarthrosis

Coxarthrosis

Germany
Nabriva Therapeutics AG

Recruiting

PK Study of Single-Dose ZTI-01 in Children (<12 Years of Age) (Pediatric_PK)

Pediatric ALL

United States
Sandoz
Hexal AG

Active, not recruiting

Non-interventional, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Stem Cell Donors (SMART)

Hematopoietic Stem Cell Mobilization

Germany
Alvotech Swiss AG

Completed

AVT03 With Xgeva in Healthy Male Subjects

This is a Phase I Study Conducted in Healthy Volunteers

United Kingdom, South Africa, Poland
Alvotech Swiss AG

Active, not recruiting

Clinical Study to Compare Efficacy and Safety of AVT06 and EU-Eylea (ALVOEYE) (ALVOEYE)

Neovascular (Wet) AMD

Slovakia, Czechia, Georgia, Japan, Latvia
Advanced Bionics AG

Completed

Investigation of the Automatic Technology on the Naída M Hearing Devices

Cochlear Hearing Loss

Switzerland
Noema Pharma AG

Completed

A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus)

Childhood-Onset Fluency Disorder

United States, Australia
Numab Therapeutics AG

Terminated

A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors

Colorectal Cancer | Fallopian Tube Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Peritoneal Carcinoma | Head and Neck Squamous Cell Carcinoma | Ovarian Carcinoma | Squamous Cell Carcinoma

United States, Taiwan, Spain
Cellestia Biotech AG

Terminated

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

Breast Cancer | Adenoid Cystic Carcinoma | Hepatocellular Carcinoma | Colorectal Cancer | Osteosarcoma | Non-hodgkin Lymphoma | Glomus Tumor, Malignant | T-ALL

United States, Spain, Korea, Republic of, Germany, France, Switzerland
pfm medical ag

Completed

Post Market Clinical Follow Up to "Patient Reported Outcome" Using a Titanised Polypropylene Mesh (TiLOOP® Bra Pocket) (PRO-Pocket)

Breast Cancer | Breast Diseases | Breast Neoplasm | Breast Reconstruction After Mastectomy

Germany, Austria
Lallemand Pharma AG

Completed

BАbykids Spray In Common Cold (BASICC)

Common Cold | Rhinitis Viral

Bulgaria
Lallemand Pharma AG

Completed

Testing the Efficacy in Adults With Cold of HEalsea Rescue* (TEACHER)

Common Cold

Bulgaria
Ivoclar Vivadent AG

Completed

Clinical Investigation of the F-Composite 2 System in Direct Filling Therapy

Dental Caries | Unsatisfactory or Defective Restoration of Tooth

Liechtenstein
Siva Health AG

Enrolling by invitation

Validation Study With a Non-CE Marked Medical Device (MD)

Chronic Cough

United States
Molecular Partners AG

Terminated

MP0250 DARPin® Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC

EGFR-mutated NSCLC (Disorder)

United States
Straub Medical AG

Active, not recruiting

Post-Market Clinical Follow-up Study With ASPIREX®S to Assess the Safety and Effectiveness in the Treatment of DVT (P-MAX)

Deep Vein Thrombosis | Bypass Complication | Dialysis Shunt | Stent Occlusion

Austria, Germany, France, Ireland, Italy
Straub Medical AG

Completed

PMCF of Rotarex®S & Aspirex®S Catheters in Treating Thrombotic Occlusion of Arteriovenous Graft

Arteriovenous Graft Thrombosis

Czechia

Clinical Trials Sponsored by Birken AG

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations